Schools Adopt Face Recognition in the Name of Fighting Covid
By Gregory Barber,
Wired
| 11. 03. 2020
IN JUNE, THE school board in Rio Rancho, New Mexico, was facing a series of votes on the budget for an elaborate and expensive reopening plan. Among the big-ticket items was a tablet designed to screen students and staff for fevers. The devices were sold by a company named OneScreen, which supplies schools with technology including “smart” whiteboards and attendance apps. But this spring, it had pivoted. Its new product, called GoSafe, could scan foreheads for elevated temperatures and detect when students aren’t wearing masks. It also came with a bonus: “top-of-the-line” facial recognition, as a local vendor described it to the school board.
District officials considered this a selling point. The tablets were pricey—$161,000 for 71 devices—even amid the district’s bulk orders of hand sanitizer and protective equipment. But they would get kids through school doors more efficiently than handheld thermometers. The facial recognition tech offered another benefit: The money would not necessarily go to waste as soon as there was a Covid-19 vaccine. The district could use the devices for other things, like taking attendance or preventing intruders...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...